PMID: 11932056Apr 5, 2002Paper

Intractable postherpetic itch and cutaneous deafferentation after facial shingles

Pain
Anne Louise OaklanderShubha V Y Raju

Abstract

Some patients develop chronic itch from neurological injuries, and shingles may be a common cause. Neuropathic itch can lead to self-injury from scratching desensate skin. A 39-year-old woman experienced severe postherpetic itch, but no postherpetic neuralgia, after ophthalmic zoster. Within 1 year, she had painlessly scratched through her frontal skull into her brain. Sensory testing and skin biopsies were performed on itchy and normal scalp to generate preliminary hypotheses about mechanisms of neuropathic itch. Quantitation of epidermal neurites in PGP9.5-immunolabeled skin biopsies demonstrated loss of 96% of epidermal innervation in the itchy area. Quantitative sensory testing indicated severe damage to most sensory modalities except itch. These data indicate that in this patient, severe postherpetic itch was associated with loss of peripheral sensory neurons. Possible mechanisms include electrical hyperactivity of hypo-afferented central itch-specific neurons, selective preservation of peripheral itch-fibers from neighboring unaffected dermatomes, and/or imbalance between excitation and inhibition of second-order sensory neurons.

References

Jun 1, 1975·The British Journal of Dermatology·V C Adreev, I Petkov
Sep 1, 1991·The Journal of Investigative Dermatology·D R SpringallJ M Polak
Apr 1, 1988·Journal of Neurophysiology·R K GarnsworthyR A Westerman
Oct 19, 1974·British Medical Journal·K Liddell
Jun 1, 1984·Neurology·M J Sullivan, M E Drake
Jan 1, 1981·Journal of Neurology, Neurosurgery, and Psychiatry·M YamamotoS Otsuki
Apr 14, 1993·JAMA : the Journal of the American Medical Association·S E Straus
Oct 5, 1996·Lancet·M W Greaves, P D Wall
Nov 30, 1996·Lancet·J D Bernhard
Nov 18, 1998·Annals of Neurology·A L OaklanderR A Meyer
Aug 26, 1999·Journal of the European Academy of Dermatology and Venereology : JEADV·N Raison-PeyronJ Meynadier

❮ Previous
Next ❯

Citations

Feb 28, 2003·Lancet·Gil YosipovitchMartin Schmelz
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Anne Louise OaklanderMark P Jensen
May 8, 2008·Nature Clinical Practice. Neurology·Andreas BinderRalf Baron
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert H DworkinRichard J Whitley
Aug 29, 2003·Regional Anesthesia and Pain Medicine·Mohamed A ElkershZahid H Bajwa
Apr 23, 2008·The Clinical Journal of Pain·Valentina Semionov, Pesach Shvartzman
Jan 24, 2007·Anesthesia and Analgesia·Joshua PaticoffAnne Louise Oaklander
Sep 15, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Steve DavidsonGlenn J Giesler
Jan 10, 2012·American Journal of Clinical Dermatology·Ashley R CurtisGil Yosipovitch
Jun 25, 2013·Brain : a Journal of Neurology·Amar Dhand, Michael J Aminoff
Nov 9, 2012·Journal of Burn Care & Research : Official Publication of the American Burn Association·Ioannis Goutos
Jul 28, 2004·Anesthesiology·Quinn HoganJ Bruce McCallum
Jun 29, 2005·Anesthesiology·Beverly WaxlerSara F Rabito
Feb 18, 2016·Current Pain and Headache Reports·Graham R HadleyAlan D Kaye
Jan 19, 2016·Journal of the American Academy of Dermatology·Nora K ShumwayKristen Heins Fernandez
Jul 20, 2011·Seminars in Cutaneous Medicine and Surgery·Anne Louise Oaklander
Jun 1, 2010·Dermatologic Clinics·Jamison D FeramiscoMartin Steinhoff
Nov 6, 2008·The Journal of Pain : Official Journal of the American Pain Society·Earl Carstens
Jul 16, 2008·The Journal of Pain : Official Journal of the American Pain Society·Kori L BrewerRobert P Yezierski
Apr 7, 2005·International Journal of Dermatology·Jon R Ward, Jeffrey D Bernhard
Apr 5, 2013·Dermatologic Therapy·Lilit GaribyanEthan A Lerner
Apr 11, 2012·Journal of Intellectual Disability Research : JIDR·Frank J SymonsChris Oliver
Nov 19, 2011·Experimental Dermatology·Ghada A Bin SaifGil Yosipovitch
Dec 8, 2004·Journal of the American Academy of Dermatology·Siong-See LeeChee-Leok Goh
Nov 29, 2005·Journal of the American Academy of Dermatology·Anne Louise Oaklander, Sandra M Siegel
Oct 16, 2004·International Journal of Dermatology·Mustafa Ozdemir, Yalcin Tüzün
Jun 15, 2007·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Fábio Kurogi AlvarezJosé Tadeu Tesseroli de Siqueira
Mar 6, 2008·Dermatologic Therapy·Gil Yosipovitch, Lena S Samuel
Jul 30, 2009·The Journal of Pain : Official Journal of the American Pain Society·Gordon J WoodGil Yosipovitch
Jan 23, 2014·Diabetes Research and Clinical Practice·David DorfmanDavid M Simpson
Nov 9, 2010·Trends in Neurosciences·Steve Davidson, Glenn J Giesler
Jul 28, 2004·Pain·Mary Ellen McCannCharles Berde
Jan 31, 2008·The Journal of Pain : Official Journal of the American Pain Society·Anne Louise Oaklander
Aug 26, 2016·Indian Dermatology Online Journal·Asit MittalAshok Kumar Khare
Apr 9, 2009·Expert Opinion on Pharmacotherapy·David G Partridge, Michael W McKendrick
Mar 2, 2017·The New England Journal of Medicine·Thomas RuzickaUNKNOWN XCIMA Study Group
May 22, 2004·Journal of the American Academy of Dermatology·Seetha U MonradDavid M Aronoff
Aug 19, 2017·Science·Di MuYan-Gang Sun
Feb 2, 2018·Pain·Junichi HachisukaSarah E Ross
Jul 29, 2018·Scientific Reports·Xiao GengZongxiang Tang
Feb 16, 2019·BioMed Research International·Ploysyne Rattanakaemakorn, Poonkiat Suchonwanit
Mar 25, 2020·JA Clinical Reports·Nobuhiro ShimadaMamoru Takeuchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.